Chronic clomipramine and triiodothyronine increase serotonin levels in rat frontal cortex in vivo: Relationship to serotonin autoreceptor activity

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 1, 1999, Pages 81-87

  Gur, Eitan ^a   Lerer, Bernard ^a   Newman, Michael E ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; CITALOPRAM; CLOMIPRAMINE; LIOTHYRONINE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; SEROTONIN; SEROTONIN 1 ANTAGONIST; SEROTONIN 1A AGONIST; THYROID HORMONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DESENSITIZATION; DRUG POTENTIATION; FRONTAL CORTEX; HORMONE ACTION; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RAT; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; CEREBRAL CORTEX; CLOMIPRAMINE; RATS; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TRIIODOTHYRONINE;

EID: 0032909487     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Adell A and Artigas F (1991) Differential effects of clomipramine given locally or systemically on extracellular 5-HT in raphe nuclei and frontal cortex. Naunyn-Schmiedeberg's Arch Pharmacol 343:237-244.
2. Arborelius L, Nomikos GG, Hertel P, Salmi P, Grillner P, Hook BB, Hacksell U and Svensson TH (1996) The 5-HT-1a receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram. NS Arch Pharmacol 353:630-640.
3. Aronson R, Offman HJ, Joffe RT and Naylor CD (1996) Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis. Arch Gen Psychiatiatry 53:842-848.
4. Auerbach SB and Hjorth S (1995) Effect of chronic administration of the selective serotonin uptake inhibitor citalopram on extracellular 5-HT and apparent auto-receptor sensitivity in rat forebrain in vivo. NS Arch Pharmacol 352:597-606.
5. Bel N and Artigas F (1996) In vivo effects of the simultaneous blockade of serotonin and norepinephrine transporters on serotonergic function: Microdialysis studies. J Pharmacol Exp Ther 278:1064-1072.
6. Blier P and Bouchard C (1994) Modulation of 5-HT release in the guinea-pig brain following long-term administration of antidepressant drugs. Br J Pharmacol 113: 485-495.
7. Blier P and de Montigny C (1994) Current advances and trends in the treatment of depression. Trends Pharmacol Sci 15:220-226.
8. Blier P, Serrano A and Scatton B (1990) Differential responsiveness of the rat dorsal and median raphe 5-HT systems to 5-HT-1 receptor agonists and p-chloroaraphetamine. Synapse 5:120-133.
9. Bosker FJ, Klompmakers AA and Westenberg HGM (1995a) Effects of single and repeated oral administration of fluvoxamine on extracellular serotonin in the median raphe nucleus and dorsal hippocampus of the rat. Neuropharmacology 34:501-508.
10. Bosker FJ, van Essevelt KE, Klompmakers AA and Westenberg HGM (1995b) Chronic treatment with fluvoxamine by osmotic minipumps fails to induce persistent functional changes in central 5-HT-1a and 5-HT-1b receptors, as measured by in vivo microdialysis in dorsal hippocampus of conscious rats. Psychopharmacology 117:358-363.
11. Brochet DM, Martin P, Soubrie P and Simon, P (1987) Triiodothyronine potentiation of antidepressant-induced reversal of learned helplessness in rats. Psychiatr Res 21:267-275.
12. Carboni E and di Chiara G (1989) Serotonin release estimated by transcortical dialysis in freely- moving rats. Neuroscience 32:637-645.
13. Contreras CM, Marvan ML and Munoz-Mendez AM (1993) Clomipramine increases the responsiveness of raphe-cortical neurons in the rat. Neuropsychobiology 27: 199-203.
14. Davidson C and Stamford JA (1995) The effect of paroxetine on 5-HT efflux in the rat dorsal raphe nucleus is potentiated by both 5-HT-la and 5-HT-1b/d receptor antagonists. Neurosci Lett 188:41-44.
15. Davidson C and Stamford JA (1997) Synergism of 5-HT-1b/1d antagonists with paroxetine on serotonin efflux in rat ventral lateral geniculate nucleus slices. Brain Res Bull 43:405-409.
16. de Montigny C and Aghajanian GK (1978) Tricyclic antidepresaants: Long-term treatment increases responsivity of rat forebrain neurons to serotonin. Science (Wash DC) 202:1303-1306.
17. El Mansari M, Bouchard C and Blier P (1995) Alteration of serotonin release in the guinea pig orbito-frontal cortex by selective serotonin reuptake inhibitors. Neuropsychopharmacology 13:117-127.
18. Friedman E and Cooper TB (1983) Pharmacokinetics of chlorimipramine and its demethylated metabolite in blood and brain regions of rats treated acutely and chronically with chlorimipramine. J Pharmacol Exp Ther 225:387-390.
19. Fujita K, Kobayashi A, Suzuki S and Nakazawa K (1991) Changes of serotonin and catecholamines are related to pharmacokinetic alterations of clomipramine in rat brain. Eur J Pharmacol 204:227-233.
20. Gobert A, Rivet J-M, Cistarelli L and Millan MJ (1997) Potentiation of the fluoxetine- induced increase in dialysate levels of serotonin in the frontal cortex of freely moving rats by combined blockade of 5-HT-1a and 5-HT-1b receptors with WAY 100,635 and GR 127,935. J Neurochem 68:1159-1163.
21. 3H]paroxetine binding to cerebral cortical membranes of the rat. Neuropharmacology 26:1087-1092.
22. Gur E, Lerer B and Newman ME (1997) Chronic electroconvulsive shock and 5-HT autoreceptor activity in rat brain: an in vivo microdialysis study. J Neural Transm 104: 795-804.
23. Heal DJ and Smith SL (1988) The effects of acute and repeated administration of T3 to mice on 5-HT-1 and 5-HT-2 function in the brain and its influence on the actions of repeated electroconvulsive shock. Neuropharmacology 27:1239-1248.
24. Hjorth S and Auerbach SB (1994) Lack of 5-HT-1a autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis. Neuropharmacology 33:331-334.
25. Hutson PH, Bristow LJ, Cunningham JR, Hogg JE, Longmore J, Murray F, Pearce D, Razzaque Z, Saywell, K, Tricklebank MD and Young L (1995) The effects of GR 127935, a putative 5-HT-1d receptor antagonist, on brain 5-HT metabolism, extracellular 5-HT concentration and behaviour in the guinea-pig. Neuropharmacology 34:383-392.
26. Invernizzi R, Bramante M and Samanin H (1994) Chronic treatment with citalopram facilitates the effect of a challenge dose on cortical serotonin output: Role of presynaptic 5-HT-1a receptors. Eur J Pharmacol 260:243-246.
27. Invernizzi R, Bramante M, and Samanin R (1996) Role of 5-HT-1a receptors in the effects of acute and chronic fluoxetine on extracellular serotonin in the frontal cortex. Pharmacol Biochem Behav 54:143-147.
28. Joffe RT, Sokolov STH and Singer W (1995) Thyroid hormone treatment of depression. Thyroid 5:235-239.
29. Kreiss DS, and Lucki I (1995) Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-HT measured in vivo. J Pharmacol Exp Ther 274:866-876.
30. Lesch K-P, Aulakh CS, Wolozin BL, Tolliver TJ, Hill JL and Murphy DL (1993) Regional brain expression of serotonin transporter mRNA and its regulation by reuptake inhibiting antidepressants. Mol Brain Res 17:31-35.
31. Maudhuit C, Hamon M and Adrien J (1995) Electrophysiological activity of raphe dorsalis serotoninergic neurones in a possible model of endogenous depression. Neuroreport 6:681-684
32. 125I]cyanopindolol binding to 5-HT-1b receptors in rat brain. Eur J Pharmacol 196:327-329.
33. Moret C and Briley M (1996) Effects of acute and repeated administration of citalopram on extracellular levels of serotonin in rat brain. Eur J Pharmacol 295:189-197.
34. Newman ME, Shapira B and Lerer B (1993) 5-HT-1a receptor-mediated effects of antidepressants. Proc Neuro-Psychopharmacol Biol Psychiat 17:1-19.
35. Paxinos G and Watson C (1986) The Rat Brain in Stereotaxic Co-ordinates, 2nd ed., Academic Press, Sydney.
36. Pineyro G, Blier P, Dennis T and de Montigny C (1994) Desensitization of the neuronal 5-HT carrier following its long-term blockade. J Neurosci 14:3036-3047.
37. 1B knock-out mice. NeuroReport 7:353-359.
38. 3H]imipramine binding in platelets after chlorimipramine in healthy volunteers. Biol Psychiatry 22:287-302.
39. Roberts C, Price GW and Jones BJ (1997) The role of 5-HT-1b/1d receptors in the modulation of 5-hydroxytryptamine levels in the frontal cortex of the conscious guinea-pig. Eur J Pharmacol 326:23-30
40. Rollema H, Clarke T, Sprouse JS and Schulz DW (1996) Combined administration of a 5-HT- 1d antagonist and a 5-HT reuptake inhibitor synergistically increases 5-HT release in guinea pig hypothalamus in vivo. J Neurochem 67:2204-2207.
41. Romero L, Hervas I and Artigas F (1996) The 5-HT-la antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain. Neurosci Lett 219:123-126.
42. Sandrini M, Vitale G, Vergoni AV, Ottani A and Bertolini A (19961 Effect of acute and chronic treatment with triiodothyronine on serotonin levels and serotonergic receptor subtypes in the rat brain. Life Sci 58:1551-1559.
43. Sharp T, Umbers V and Gartside SE (1997) Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT-1a and 5-HT-1b receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo. Br J Pharmacol 121:941-946.
44. Skingle M, Sleight AJ and Feniuk W (1995) Effects of the 5-HT-1d receptor antagonist GR 127935 on extracellular levels of 5-HT in the guinea-pig frontal cortex as measured by microdialysis. Neuropharmacology 34:377-382.
45. Sleight AJ, Smith RJ, Marsden CA and Palfreyman MG (1989) The effects of chronic treatment with amitriptyline and MDL 72394 on the control of 5-HT release in vivo. Neuropharmacology 28:477-480.